Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE

Bone

Volumn 27, Issue 1, 2000, Pages 29-40

  Lean, J M ^a   Matsuo, K ^c   Fox, S W ^a   Fuller, K ^a   Gibson, F M ^b   Draycott, G ^b   Wani, M R ^a   Bayley, K E ^a   Wong, B R ^e   Choi, Y ^d   Wagner, E F ^c   Chambers, T J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cell line; Cell lineage; Macrophage; Osteoclast; TRANCE

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IMMUNOCHEMISTRY; MACROPHAGE; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHASE CONTRAST MICROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RETROVIRIDAE;

EID: 18344404083     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00306-9     Document Type: Article

References (43)

1. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
2. Burgess T.L., Qian Y.-X., Kaufman S., Ring B.D., Van G., Capparelli C., Kelly M., Hsu H., Boyle W.J., Dunstan C.J., Hu S., Lacey D.L. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 145:1999;527-538.
3. Burstone M.S. Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J Natl Cancer Inst. 21:1958;423-539.
4. Chambers T.J. Regulation of osteoclast development and function. Rifkin B.R., Gay C.V. Biology and Physiology of the Osteoclast. 1992;105-128 CRC Press, Boca Raton.
5. Chambers T.J., McSheehy P.M.J., Thomson B.M., Fuller K. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 116:1985;234-239.
6. btsA58 transgenic mouse. Proc Natl Acad Sci USA. 90:1993;5578-5582.
7. Chen W., Li Y.P. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J Bone Miner Res. 13:1998;1112-1113.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocynate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
9. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., de Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey P.J., Peschon J.J., Schuh J. RANK is essential for osteoclast and lymph node development. Genes Develop. 13:1999;2412-2424.
10. Eckner R., Ludlow J.W., Lill N.L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J.A., Livingston D.M., Morgan J.A. Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol. 16:1996;3454-3464.
11. Fuller K., Chambers T.J. Bone matrix stimulates osteoclastic differentiation in cultures of rabbit bone marrow cells. J Bone Miner Res. 4:1989;179-183.
12. Fuller K., Chambers T.J. Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 4:1989;209-215.
13. Fuller K., Wong B., Fox S., Choi Y., Chambers T.J. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med. 188:1998;997-1001.
14. Goldring S.R., Roelke M., Glowacki J. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin. J Bone Miner Res. 3:1988;117-120.
15. Grell M., Douni E., Wajant H., Lönden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:1995;793-802.
16. Hattersley G., Chambers T.J. Calcitonin receptors as markers for osteoclastic differentiation correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures . Endocrinology. 125:1989;1606-1612.
17. Henry C., Marbrook J., Vann D.C., Kodlin D., Wofsy C. Limiting dilution analysis. Mishell B.B., Shiigi S.M. Selected Methods in Cellular Immunology. 1980;138-152 W. H. Freeman, San Francisco.
18. Hentunen T.A., Cunningham N.S., Vuolteenaho O., Reddi A.H., Väänänen H.K. Osteoclast recruiting activity in bone matrix. Bone Miner. 25:1994;183-198.
19. L and simian virus 40 large antigen. Endocrinology. 140:1999;2954-2961.
20. Hirsch S., Austen J.M., Gordon S. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med. 154:1981;713-725.
21. Horwood N.J., Eliott J., Martin T.J., Gillespie M.T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 139:1998;4743-4746.
22. Hume D.A., Loutit J.F., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80 macrophages of bone and associated connective tissue . J Cell Sci. 66:1984;189-194.
23. Hume D.A., Robinson A.P., MacPherson G.G., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med. 158:1983;1522-1536.
24. Jones S.J., Boyde A. Morphological changes of osteoblasts in vitro. Cell Tiss Res. 166:1976;101-107.
25. Kong Y.-Y., Yoshida H., Sarosi I., Tan H.-L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323.
26. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T. E., R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176; 1998.
27. Lakkakorpi P., Tuukkanen J., Hentunen T., Järvelin K., Väänänen K. Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res. 4:1989;817-825.
28. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer separating viral genes on two different plasmids . J Virol. 62:1988;1120-1124.
29. McSheehy P.M.J., Chambers T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:1986;824-828.
30. Miyamoto A., Kunisada T., Hemmi H., Yamane T., Yasuda H., Miyake K., Yamazaki H., Hayashi S.-I. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem Biophys Res Commun. 242:1998;703-709.
31. Morgenstern J.P., Land H. Advanced mammalian gene transfer high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line . Nucl Acids Res. 18:1990;3587-3596.
32. Nesbitt S., Nesbit A., Helfrich M., Horton M. Biochemical characterization of human osteoclast integrins. J Biol Chem. 268:1993;16737-16745.
33. Owens J.M., Gallagher A.C., Chambers T.J. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem Biophys Res Commun. 222:1996;225-229.
34. Owens J.M., Matsuo K., Nicholson G.C., Wagner E.F., Chambers T.J. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol. 179:1999;170-178.
35. Quinn J.M.W., Morfis M., Lam M.H.C., Elliott J., Kartsogiannis V., Williams E.D., Gillespie M.T., Martin T.J., Sexton P.M. Calcitonin receptor antibodies in the identification of osteoclasts. Bone. 25:1999;1-8.
36. Shin J.H., Kukita A., Ohki K., Katsuki T., Kohashi O. In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells. Endocrinology. 136:1995;4285-4292.
37. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.-S., Lüthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Columbero A., Tan H.-L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Program A.E., Boyle W.J. Osteoprotegerin a novel secreted protein involved in the regulation of bone density . Cell. 89:1997;309-319.
38. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr Rev. 13:1992;66-79.
39. Walker W.S. Establishment of mononuclear phagocyte cell lines. J Immunol Meth. 174:1994;25-31.
40. 2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors synergistic activation of differentiation, cell spreading, and fusion . Endocrinology. 140:1999;1927-1935.
41. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.-L., Steinman R.M., Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med. 186:1997;2075-2080.
42. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., Kalachikov S., Cayani E., Bartlett F.S. III, Frankel W.N., Lee S.Y., Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190-25194.
43. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S.-I., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.